GTR 69197619
Grants Notice For Mechanisms That Impact Cancer Risk With Use Of Incretin Mimetics (R01clinical Trial Optional
ICB — International Competitive Bid
Closes Jan 07, 2027
Americas
Tender Information
GTR Reference
69197619
Tendering Authority
Subscribe to view
Tender No
PAR-23-279
Financer Name
Self-Funded
Work Title
Grants Notice For Mechanisms That Impact Cancer Risk With Use Of Incretin Mimetics (R01clinical Trial Optional
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Americas
Political Region
Asia Pacific Economic Cooperation APEC,APAC Asia Pacific
Last Date of Bid Submission
07-01-2027
Work Detail
Mechanisms That Impact Cancer Risk With Use Of Incretin Mimetics (R01clinical Trial Optional The Goal Of The Proposed Funding Announcement Is Twofold, To Promote Preclinical And Patient Based Studies Examining The Mechanism(S) Through Which Incretin Mimetics (Including Agonists Or Antagonists Of Glp-1, Gip-1, Or Dual Glp-1/Gip-1 Agents) Impact Cancer Risk, And To Draw Talented Scientists Who Understand The Dynamic Changes Caused By These Agents To Investigate The Mechanisms Of How These Agents Influence Cancer Risk Rather Than Shorter Term Outcomes Such As Weight Loss And Diabetes. The Data Thus Far Suggests That These Agents May Increase The Risk Of Some, While Decreasing The Risk Of Other Obesity Related Cancers
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
5e089310-f7db-4690-89c0-c24b2e52e68e.pdf
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.